标题
Past, present and future targets for immunotherapy in ovarian cancer
作者
关键词
-
出版物
Immunotherapy
Volume 6, Issue 12, Pages 1279-1293
出版商
Future Medicine Ltd
发表日期
2014-12-19
DOI
10.2217/imt.14.90
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression
- (2014) Isabelle Matte et al. BMC CANCER
- Macrophage Migration Inhibitory Factor Contributes to the Immune Escape of Ovarian Cancer by Down-Regulating NKG2D
- (2014) M. Krockenberger et al. JOURNAL OF IMMUNOLOGY
- Diverse Solid Tumors Expressing a Restricted Epitope of L1-CAM Can Be Targeted by Chimeric Antigen Receptor Redirected T Lymphocytes
- (2014) Hao Hong et al. JOURNAL OF IMMUNOTHERAPY
- Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody-Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect
- (2014) S. Golfier et al. MOLECULAR CANCER THERAPEUTICS
- PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer
- (2014) Zhiqiang Guo et al. PLoS One
- Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
- (2014) K. Odunsi et al. Cancer Immunology Research
- The Role of Mesothelin in Tumor Progression and Targeted Therapy
- (2013) Zhewei Tang et al. Anti-Cancer Agents in Medicinal Chemistry
- Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer
- (2013) Deborah K. Armstrong et al. GYNECOLOGIC ONCOLOGY
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study
- (2013) Paul Sabbatini et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin
- (2013) A. C. Parente-Pereira et al. JOURNAL OF IMMUNOLOGY
- A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
- (2013) Lana E Kandalaft et al. Journal of Translational Medicine
- The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus
- (2013) L Zhang et al. ONCOGENE
- Cells, Stem Cells, and Cancer Stem Cells
- (2013) Cristóbal Aguilar-Gallardo et al. SEMINARS IN REPRODUCTIVE MEDICINE
- Blocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responses
- (2013) Denarda Dangaj et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Naturally circulating dendritic cells to vaccinate cancer patients
- (2013) Kalijn F. Bol et al. OncoImmunology
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Will T-cell therapy for cancer ever be a standard of care?
- (2012) M K Brenner CANCER GENE THERAPY
- Trifunctional Bispecific Antibodies Induce Tumor-Specific T Cells and Elicit a Vaccination Effect
- (2012) Nina Eissler et al. CANCER RESEARCH
- CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
- (2012) J. S. Nielsen et al. CLINICAL CANCER RESEARCH
- Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer
- (2012) Stephen E. Wright et al. JOURNAL OF IMMUNOTHERAPY
- A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer
- (2012) Lana E Kandalaft et al. Journal of Translational Medicine
- Mesothelin-Targeted Agents in Clinical Trials and in Preclinical Development
- (2012) R. J. Kelly et al. MOLECULAR CANCER THERAPEUTICS
- Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients
- (2012) K. Odunsi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AAV2/IL-12 gene delivery into dendritic cells (DC) enhances CTL stimulation above other IL-12 applications
- (2012) Chang-Xuan You et al. OncoImmunology
- A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
- (2011) Osama E. Rahma et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
- (2011) Christina S. Chu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
- (2011) D.-G. Song et al. CANCER RESEARCH
- A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
- (2011) D. T. Le et al. CLINICAL CANCER RESEARCH
- Dendritic cell–tumor cell hybrids and immunotherapy: what's next?
- (2011) Dominique Cathelin et al. CYTOTHERAPY
- The Suppressive Tumor Microenvironment: A Challenge in Cancer Immunotherapy
- (2011) Elizabeth A. Vasievich et al. MOLECULAR PHARMACEUTICS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Human Ovarian Tumor Cells Escape γδ T Cell Recognition Partly by Down Regulating Surface Expression of MICA and Limiting Cell Cycle Related Molecules
- (2011) Jingwei Lu et al. PLoS One
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- CA 125 and the detection of recurrent ovarian cancer
- (2010) Robert C. Bast CANCER
- Successful Eradication of Established Peritoneal Ovarian Tumors in SCID-Beige Mice following Adoptive Transfer of T Cells Genetically Targeted to the MUC16 Antigen
- (2010) A. A. Chekmasova et al. CLINICAL CANCER RESEARCH
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
- (2010) Markus M. Heiss et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of Epithelial Cell Adhesion Molecule in Primary, Metastatic, and Recurrent/Chemotherapy-Resistant Epithelial Ovarian Cancer
- (2010) Stefania Bellone et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Tumor-infiltrating NY-ESO-1–specific CD8+T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
- (2010) Junko Matsuzaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy
- (2010) Axel Hoos et al. SEMINARS IN ONCOLOGY
- PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
- (2009) L. Zhang et al. BLOOD
- Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer
- (2009) Stefania Bellone et al. CANCER
- Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival
- (2009) Mark J. Dobrzanski et al. CLINICAL IMMUNOLOGY
- New Perspectives for Melanoma Immunotherapy: Role of IL-12
- (2009) Claudia Cocco et al. CURRENT MOLECULAR MEDICINE
- Ovarian cancer tumor infiltrating T-regulatory (Treg) cells are associated with a metastatic phenotype
- (2009) Jason C. Barnett et al. GYNECOLOGIC ONCOLOGY
- The Lewis-Y Carbohydrate Antigen is Expressed by Many Human Tumors and Can Serve as a Target for Genetically Redirected T cells Despite the Presence of Soluble Antigen in Serum
- (2009) Jennifer A. Westwood et al. JOURNAL OF IMMUNOTHERAPY
- Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model
- (2008) S H Yoon et al. CANCER GENE THERAPY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Antigen-specific immunotherapy of cervical and ovarian cancer
- (2008) Chien-Fu Hung et al. IMMUNOLOGICAL REVIEWS
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Sperm Protein 17 is a Suitable Target for Adoptive T-cell–based Immunotherapy in Human Ovarian Cancer
- (2008) Maurizio Chiriva-Internati et al. JOURNAL OF IMMUNOTHERAPY
- The Immune Adjuvant Properties of Front-line Carboplatin-Paclitaxel: A Randomized Phase 2 Study of Alternative Schedules of Intravenous Oregovomab Chemoimmunotherapy in Advanced Ovarian Cancer
- (2008) Patricia Braly et al. JOURNAL OF IMMUNOTHERAPY
- Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
- (2008) Shuichi Izumoto et al. JOURNAL OF NEUROSURGERY
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
- WT1-specific T cell receptor gene therapy: Improving TCR function in transduced T cells
- (2007) Hans J. Stauss et al. BLOOD CELLS MOLECULES AND DISEASES
- Mesothelin targeted cancer immunotherapy
- (2007) Raffit Hassan et al. EUROPEAN JOURNAL OF CANCER
- The role of dendritic cells in cytotoxic immune response regulation in ovarian cancer micro-environment
- (2007) Iwona Wertel Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started